Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial
在炎症性肠病中,从剂量强化静脉注射英夫利昔单抗转换为皮下注射英夫利昔单抗(DISCUS-IBD):一项多中心随机对照试验方案
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2023-081787
Little, Robert D; McKenzie, Jo; Srinivasan, Ashish; Hilley, Patrick; Gilmore, Robert B; Chee, Desmond; Sandhu, Manjeet; Saitta, Daniel; Chow, Elizabeth; Thin, Lena; Walker, Gareth J; Moore, Gregory T; Lynch, Kate; Andrews, Jane; An, Yoon K; Bryant, Robert V; Connor, Susan J; Garg, Mayur; Wright, Emily K; Hold, Georgina; Segal, Jonathan P; Boussioutas, Alex; De Cruz, Peter; Ward, Mark G; Sparrow, Miles P